22:28 , May 6, 2019 |  BC Extra  |  Company News

Management tracks: Batu, Halozyme, FOG

Immunotherapy company Batu Biologics Inc. , (San Diego, Calif.) said founder Thomas Ichim has become president and CEO. Ichim, also a director, was previously Batu's CSO. He succeeds founder Samuel Wagner, who stepped down and...
07:00 , Jun 22, 2015 |  BC Week In Review  |  Financial News

Batu Biologics completes venture financing

Batu Biologics Inc. , San Diego, Calif.   Business: Cancer   Date completed: 2015-06-18   Type: Venture financing   Raised: $1 million   Investors: Private investors; angel investors  ...
07:00 , Apr 13, 2015 |  BC Week In Review  |  Clinical News

Batu Biologics preclinical data

In mouse models of melanoma, breast cancer and Lewis lung carcinoma (LLC), once-weekly subcutaneous ValloVax for 4 weeks significantly reduced tumor growth and metastasis vs. untreated control placental endothelial cells and saline-treated controls. Data were...
08:00 , Nov 3, 2014 |  BC Week In Review  |  Company News

University of California, Batu Biologics deal

University of California, San Diego granted exclusive, worldwide rights to Batu to develop and commercialize 10 peptide families that the company said stimulate cancer-killing immune responses. Batu says it plans to use the peptides, which...
07:00 , Sep 15, 2014 |  BC Week In Review  |  Company News

Batu Biologics management update

Batu Biologics Inc. , San Diego, Calif.   Business: Cancer   Hired: Hong Ma as CSO  ...